Adult and adolescent patients, ages 12 and older, with hereditary angioedema (HAE)Â in Israel can now receive once-daily…
Articles by Steve Bryson, PhD
A Japanese woman was diagnosed with a rare case of non-episodic angioedema associated with eosinophilia (NEAE), with remarkably…
Researchers have developed a simple scoring system to help clinicians identify angioedema patients at high or low…
The Phase 2 KOMPLETE clinical trial testing the ability of oral KVD824 to prevent attacks in people with…
KalVista Pharmaceuticals has launched a two-year open-label extension (OLE) study, dubbed KONFIDENT-S, to test the long-term safety of oral…
Regulatory authorities in Saudi Arabia have approved daily Orladeyo (berotralstat) to prevent hereditary angioedema (HAE) attacks in adult…
STAR-0215, an investigational therapy to prevent swelling attacks in people with hereditary angioedema (HAE), rapidly and durably suppressed the…
Treatment with sebetralstat, an investigational and oral on-demand therapy, resulted in rapid relief for both abdominal and peripheral attacks in…
The one-year Phase 3 SPRING study evaluating the safety, efficacy, and pharmacological properties of Takhzyro (lanadelumab) in children with…
CSL Plasma has donated $125,000 to the American Red Cross to support recovery and relief efforts following disasters…